image
Healthcare - Biotechnology - NASDAQ - US
$ 0.4906
-5.83 %
$ 20.3 M
Market Cap
-0.52
P/E
BALANCE SHEET
104 M ASSETS
21.36%
27.4 M LIABILITIES
59.87%
76.5 M EQUITY
11.71%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Spruce Biosciences, Inc.
image
Current Assets 102 M
Cash & Short-Term Investments 96.3 M
Receivables 0
Other Current Assets 5.84 M
Non-Current Assets 1.76 M
Long-Term Investments 0
PP&E 1.18 M
Other Non-Current Assets 582 K
Current Liabilities 24.5 M
Accounts Payable 3.33 M
Short-Term Debt 1.87 M
Other Current Liabilities 19.3 M
Non-Current Liabilities 2.97 M
Long-Term Debt 2.74 M
Other Non-Current Liabilities 236 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 96.3 24.5 42.7 157.2 3.9 4.1
Short Term Investments 0 54.6 46.2 0 0 0
Receivables 0 0 0 0 0 0
Inventory 0 0 0 0 0 0
Other Current Assets 5.8 4.5 2.9 3.2 0.7 0.7
Total Current Assets 102.2 83.6 91.9 160.4 4.7 4.8
PP&E 1.2 1.4 1.5 1.8 0 0
Intangible Assets 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0
Long Term Investments 0 (54.5) 32.5 0.2 0 0
Other Long Term Assets 0.6 55.2 0.7 0.5 40 K 2 K
Other Assets 0 0 0 0 0 0
Total Assets 103.9 85.6 126.5 162.9 4.7 4.8
LIABILITIES
Accounts Payable 3.3 1.4 2.8 3.6 1.9 2.3
Short Term Debt 1.9 1.8 0.4 2.8 1.3 0
Other Current Liabilities 14.3 9.3 5.7 3.3 1.2 0.4
Total Current Liabilities 24.5 12.4 8.9 9.8 4.3 2.7
Long Term Debt 2.7 4.6 6.2 3.6 3.2 0
Deferred Tax Income 0 0 0 0 0 0
Other Liabilities 0.2 0.2 73 K 0.1 27.8 19.9
Total Liabilities 27.4 17.2 15.1 13.5 35.3 22.6
EQUITY
Common Stock 4 K 3 K 3 K 2 K 1 K 1 K
Retained Earnings (197.2) (149.3) (103.1) (60.8) (31.3) (18.2)
Other Accumulative Comprehensive Income/Loss 0 (0.6) (0.2) (162.9) (27.8) 0
Total Equity 76.5 68.5 111.4 149.4 (30.6) (17.8)
Total Liabilities and Equity 103.9 85.6 126.5 162.9 4.7 4.8
SHARES OUTSTANDING
Common Shares Outstanding 38.5 23.5 23.4 23.3 22.3 4.9